|
[1] Manuelpillai U, Moodley Y, Borlongan C V, et al. Amniotic membrane and amniotic cells: Potential therapeutic tools to combat tissue inflammation and fibrosis? Placenta,2011,32(4):320-325.
[2] Chang C J, Yen M L, Chen Y C, et al. Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells,2006,24:2466-2477.
[3] Banas R A, Trumpower C, Jewski C B,et al. Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells. Human Immunology,2008,69:321-328.
[4] Ilancheran S, Michalska A, Peh G, et al. Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod, 2007,77:577-588.
[5] Bilic G, Zeisberger S M, Mallik A S, et al. Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy. Cell Transplant, 2008,17:955-968.
[6] Ilancheran S, Moodley Y, Manuelpillai U. Human fetal membranes: a source of stem cells for tissue regeneration and repair? Placenta, 2009,30:2-10.
[7] Tamagawa T, Oi S, Ishiwata I, et al. Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte-like cells in vitro. Hum Cell, 2007,20:77-84.
[8] Tamagawa T, Ishiwata I, Sato K,et al. Induced in vitro differentiation of pancreatic-like cells from human amnion-derived fibroblast-like cells. Hum Cell, 2009,22:55-63.
[9] Zhao P, Ise H, Hongo M, et al. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation,2005;79,528-535.
[10] Sakuragawa N, Kakinuma K, Kikuchi A, et al. Human amnion mesenchyme cells express phenotypes of neuroglial progenitor cells. J Neurosci Res,2004,78:208-214.
[11] 杨春,杨坚,史明霞,等.多种造血细胞因子在人类羊膜间充质干细胞中表达的意义.白血病淋巴瘤,2010,19(12):732-738. Yang C,Yang J,Shi M X,et al. Journal of Leukemia & Lymphoma, 2010,19(12):732-738.
[12] Tolar J, Nauta A J, Osborn M J, et al. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells, 2007,25(2):371-379.
[13] Kim J, Kang J W, Park J H, et al. Biological characterization of long-term cultured human mesenchymal stem cells. Arch Pharm Res, 2009,32(1):117-126.
[14] Manuelpillai U, Tchongue J, Lourensz D, et al.Transplantation of human amnion epithelial cells reduces hepatic fibrosis in immunocompetent CCl(4)-treated mice. Cell Transplant, 2010,19:1157-1168.
[15] Cargnoni A, Gibelli L, Tosini A, et al.Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis. Cell Transplant, 2009,18:405-422.
[16] 朴正福,张海燕,丁淑芹,等.人羊膜间充质干细胞的生物学特性鉴定.国际生物医学工程杂志,2010,33(3):157-162. Pu Z F,Zhang H Y,Ding S Q,et al.International Journal of Biochemical Engineering,2010,33(3):157-162.
[17] Tomonori M,Tetsuya I, Yasuhiko I, et al. Differentiation of smooth muscle cells from human amniotic mesenchymal cells implanted in the freeze-injured mouse urinary bladder.European Urology,2010,58:299-306.
[18] Tomoharu T, Isamu I, Hiroshi I, et al. Induced in vitro differentiation of neural-like cells from human amnion-derived fibroblast-like cells. Human Cell, 2008, 21: 38-45.
[19] Tamagawa T, Ishiwata I, Sato K,et al. Induced in vitro differentiation of pancreatic-like cells from human amnion-derived fibroblast-like cells. Human Cell, 2009, 22: 55-63.
[20] Soncini M, Vertua E, Gibelli L, et al. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med,2007,1:296-305.
[21] Parolini O, Caruso M.Preclinical studies on placenta-derived cells and amniotic membrane:An update. Trophoblast Research,2011, 25:S186-S195.
[22] Pan H C, Yang D Y, Chiu Y T, et al. Enhanced regeneration in injured sciatic nerve by human amniotic mesenchymal stem cell. Journal of Clinical Neuroscience, 2006, 13:570-575.
[23] Tsuji H, Miyoshi S, Ikegami Y, et al. Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ Res, 2010,106:1613-1623.
[24] Wei J P, Nawata M, Wakitani S, et al. Human amniotic mesenchymal cells differentiate into chondrocytes. Cloning Stem Cells, 2009,11:19-26.
[25] Kawamichi Y, Cui C H, Toyoda M, et al. Cells of extraembryonic mesodermal origin confer human dystrophin in the mdx model of Duchenne muscular dystrophy. J Cell Physiol, 2010,223:695-702.
[26] Parolini O, Alviano F, Bergwerf I, et al. Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table. Stem Cells Dev, 2010,19:143-154.
[27] Chen M Q, Wang X, Ye Z Y,et al. A modular approach to the engineering of a centimeter-sized bone tissue construct with human amniotic mesenchymal stem cells-laden microcarriers. Biomaterials, 2011,32(30):7532-7542.
[28] Shaun A S, Azra A, Rabie M S,et al. Sternal repair with bone grafts engineered from amniotic mesenchymal stem cells. Journal of Pediatric Surgery,2009, 44:1120-1126.
[29] Parolini O, Alviano F, Bagnara G P, et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells. Stem Cells, 2008,26:300-311.
[30] Wolbank S, Peterbauer A, Fahrner M, et al. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng,2007,13:1173-1183.
[31] Magatti M, Munari S, Vertua E, et al. Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes. Cell Transplant,2009,18:899-914.
[32] Paradowska E, Blach-Olszewska Z, Gejdel E. Constitutive and induced cytokine production by human placenta and amniotic membrane at term. Placenta,1997,18:441-446.
[33] Steed D L, Trumpower C, Duffy D, et al. Amnion derived cellular cytokine solution: a physiological combination of cytokines for wound healing. Eplasty,2008,8:10-18.
|
